<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Biotek-snakken — Januar 2024]]></title><description><![CDATA[<p dir="auto">Godmorgen...</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/401439/biotek-snakken-januar-2024</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 07:32:47 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/401439.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 01 Jan 2024 06:54:06 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Wed, 31 Jan 2024 05:21:16 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066775</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066775</guid><dc:creator><![CDATA[Fandel]]></dc:creator><pubDate>Wed, 31 Jan 2024 05:21:16 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 13:32:19 GMT]]></title><description><![CDATA[<p dir="auto">Per d.d.: $22,29 ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066777</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066777</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Tue, 30 Jan 2024 13:32:19 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 13:31:17 GMT]]></title><description><![CDATA[<p dir="auto">Calliditas Therapeutics:<br />
Jefferies höjer riktkursen för Calliditas till 57 dollar per depåbevis (55), upprepar köp</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066772</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066772</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Tue, 30 Jan 2024 13:31:17 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 12:22:00 GMT]]></title><description><![CDATA[<p dir="auto">Og nu er de over 3? et eller andet (mener det er $)? Jow, øeeee er jo slet ikke med. Hvad laver jeg her!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066776</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066776</guid><dc:creator><![CDATA[oge]]></dc:creator><pubDate>Tue, 30 Jan 2024 12:22:00 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 12:19:00 GMT]]></title><description><![CDATA[<p dir="auto">Ja, ja jeg har da stadig 33 stk tilbage -</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066768</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066768</guid><dc:creator><![CDATA[oge]]></dc:creator><pubDate>Tue, 30 Jan 2024 12:19:00 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 12:17:39 GMT]]></title><description><![CDATA[<p dir="auto">Hvor "dum" kan man være, det går jo stygende der i Iterum!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066771</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066771</guid><dc:creator><![CDATA[oge]]></dc:creator><pubDate>Tue, 30 Jan 2024 12:17:39 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 30 Jan 2024 12:16:55 GMT]]></title><description><![CDATA[<p dir="auto">Iterum? Nå en kan jo ikke vinde hver gang?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066766</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066766</guid><dc:creator><![CDATA[oge]]></dc:creator><pubDate>Tue, 30 Jan 2024 12:16:55 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 12:37:07 GMT]]></title><description><![CDATA[<p dir="auto">PS: De er ved at afslutte et fase II-forsøg og har en aftale med FDA om et møde for opsætning af fase III-forsøg <a href="https://irlab.se/newsroom/pressrelease-archive/" rel="nofollow ugc">https://irlab.se/newsroom/pressrelease-archive/</a>, men det i sig selv er vel ikke tilstrækkeligt til så stor en stigning?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066770</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066770</guid><dc:creator><![CDATA[Kjølstad]]></dc:creator><pubDate>Mon, 29 Jan 2024 12:37:07 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 12:29:38 GMT]]></title><description><![CDATA[<p dir="auto">Nogen der ved, hvad der sker i IRLAB AB for tiden. Den sidste måned er den steget med 100%? (Er gået ind i dag med en lille slat spillemønter) <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066773</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066773</guid><dc:creator><![CDATA[Kjølstad]]></dc:creator><pubDate>Mon, 29 Jan 2024 12:29:38 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 09:25:32 GMT]]></title><description><![CDATA[<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://alligatorbioscience.se/en/mfn_news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/" title="Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience">
<img src="https://alligatorbioscience.se/wp-content/uploads/2020/02/Alligator-3810-1200x630.jpg" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://alligatorbioscience.se/en/mfn_news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/">
Alligator Bioscience Announces Positive Mitazalimab OPTIMIZE-1 Phase 2 Results Meeting Primary Endpoint and Demonstrating Clinically Relevant Survival Benefits in 1st Line Pancreatic Cancer – Alligator Bioscience
</a>
</h5>
<p class="card-text line-clamp-3">Top-line readout demonstrates Objective Response Rate of 40.4%, meeting primary endpoint and confirming the benefit of mitazalimab in combin ...</p>
</div>
<a href="https://alligatorbioscience.se/en/mfn_news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://alligatorbioscience.se/wp-content/uploads/2022/09/cropped-Symbol-fill-green-32x32.png" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>







<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(alligatorbioscience.se)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066769</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066769</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Mon, 29 Jan 2024 09:25:32 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 09:25:31 GMT]]></title><description><![CDATA[<p dir="auto">Alligator Bio har succes med deres CD40 monoclonale antistof Mitazalimab, så lad os håbe Genmab kan toppe den:</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066774</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066774</guid><dc:creator><![CDATA[Sukkeralf]]></dc:creator><pubDate>Mon, 29 Jan 2024 09:25:31 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 07:18:03 GMT]]></title><description><![CDATA[<p dir="auto">Gode nyheder fra alligator bio. <a href="https://alligatorbioscience.se/en/news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/" rel="nofollow ugc">https://alligatorbioscience.se/en/news/alligator-bioscience-announces-positive-mitazalimab-optimize-1-phase-2-results-meeting-primary-endpoint-and-demonstrating-clinically-relevant-survival-benefits-in-1st-line-pancreatic-cancer/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066763</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066763</guid><dc:creator><![CDATA[bibob]]></dc:creator><pubDate>Mon, 29 Jan 2024 07:18:03 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 05:28:32 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066767</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066767</guid><dc:creator><![CDATA[LP90]]></dc:creator><pubDate>Mon, 29 Jan 2024 05:28:32 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Mon, 29 Jan 2024 04:59:19 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066760</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066760</guid><dc:creator><![CDATA[Fandel]]></dc:creator><pubDate>Mon, 29 Jan 2024 04:59:19 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Sat, 27 Jan 2024 04:42:45 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066761</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066761</guid><dc:creator><![CDATA[Fandel]]></dc:creator><pubDate>Sat, 27 Jan 2024 04:42:45 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Fri, 26 Jan 2024 12:42:01 GMT]]></title><description><![CDATA[<p dir="auto">&quot;Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories.&quot;</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">



<a href="https://www.linkedin.com/posts/renee-aguiar-lucander-63373418_calliditas-receives-notice-of-allowance-for-activity-7156641395359854592-3_ZK" title="Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO® - Calliditas Therapeutics AB | Renee Aguiar-Lucander">
<img src="https://media.licdn.com/dms/image/sync/v2/D4E27AQHlJsy5DqlPJw/articleshare-shrink_800/articleshare-shrink_800/0/1771377674398?e=2147483647&v=beta&t=rdFkETeNagLqRoAEhjgvAEmSCNDDl-G-i6pNCcGbpE4" class="card-img-top not-responsive" style="max-height: 15rem;" alt="Link Preview Image" onerror="this.parentElement.remove()" />
</a>



<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.linkedin.com/posts/renee-aguiar-lucander-63373418_calliditas-receives-notice-of-allowance-for-activity-7156641395359854592-3_ZK">
Calliditas Receives Notice of Allowance for United States Patent Application Covering TARPEYO® - Calliditas Therapeutics AB | Renee Aguiar-Lucander
</a>
</h5>
<p class="card-text line-clamp-3">Exciting news as our new patent for TARPEYO now has been officially issued. This new patent, which provides protection until 2043, significantly strengthens TARPEYO’s product protection, further improving its unique value proposition. We are looking forward to continuing to expand our franchise IP protection in other territories. 

https://lnkd.in/dbqhAd_W
</p>
</div>
<a href="https://www.linkedin.com/posts/renee-aguiar-lucander-63373418_calliditas-receives-notice-of-allowance-for-activity-7156641395359854592-3_ZK" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://static.licdn.com/aero-v1/sc/h/al2o9zrvru7aqj8e1x2rzsrca" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0">LinkedIn <span class="text-secondary">(www.linkedin.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066757</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066757</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 26 Jan 2024 12:42:01 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Fri, 26 Jan 2024 06:29:01 GMT]]></title><description><![CDATA[<p dir="auto">Calliditas: Vera Therapeutics has released interesting additional 2b results</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.redeye.se/research/972489/calliditas-vera-therapeutics-has-released-interesting-additional-2b-results">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.redeye.se/research/972489/calliditas-vera-therapeutics-has-released-interesting-additional-2b-results" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.redeye.se/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.redeye.se)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066759</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066759</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Fri, 26 Jan 2024 06:29:01 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Thu, 25 Jan 2024 17:53:18 GMT]]></title><description><![CDATA[<p dir="auto">Video - Steg 220% på kun 3 dage - og jeg har aktien (Evaxion)!<br />
<a href="https://www.proinvestor.com/boards/118268" rel="nofollow ugc">https://www.proinvestor.com/boards/118268</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066765</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066765</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 25 Jan 2024 17:53:18 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Thu, 25 Jan 2024 07:27:52 GMT]]></title><description><![CDATA[<p dir="auto">Ja det har været nogle gode dage...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066754</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066754</guid><dc:creator><![CDATA[Fandel]]></dc:creator><pubDate>Thu, 25 Jan 2024 07:27:52 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Thu, 25 Jan 2024 05:39:46 GMT]]></title><description><![CDATA[<p dir="auto">Lidt nyt fra Ascelia Pharma. 24 Jan. <a href="https://www.ascelia.com/mfn_news/orviglance-review-article-published-in-investigative-radiology/" rel="nofollow ugc">https://www.ascelia.com/mfn_news/orviglance-review-article-published-in-investigative-radiology/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066756</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066756</guid><dc:creator><![CDATA[bibob]]></dc:creator><pubDate>Thu, 25 Jan 2024 05:39:46 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Wed, 24 Jan 2024 14:00:18 GMT]]></title><description><![CDATA[<p dir="auto">"Redeye’s base case is SEK280 and the share price is around SEK122."</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066762</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066762</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Wed, 24 Jan 2024 14:00:18 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Wed, 24 Jan 2024 13:58:45 GMT]]></title><description><![CDATA[<p dir="auto">Top Picks: Two smaller adjustments before the earnings season</p>
<p dir="auto">... Increasing in Calliditas (from 3.3% of the portfolio to 7%) ...</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.redeye.se/research/972048/top-picks-two-smaller-adjustments-before-the-earnings-season">
Just a moment...
</a>
</h5>
<p class="card-text line-clamp-3"></p>
</div>
<a href="https://www.redeye.se/research/972048/top-picks-two-smaller-adjustments-before-the-earnings-season" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.redeye.se/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(www.redeye.se)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066753</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066753</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Wed, 24 Jan 2024 13:58:45 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 23 Jan 2024 09:20:26 GMT]]></title><description><![CDATA[<p dir="auto">Har reduceret 50% overvejer det hele for aktien vil nok blive ved med at falde ned til de 0,3?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066752</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066752</guid><dc:creator><![CDATA[Kennethl]]></dc:creator><pubDate>Tue, 23 Jan 2024 09:20:26 GMT</pubDate></item><item><title><![CDATA[Reply to Biotek-snakken — Januar 2024 on Tue, 23 Jan 2024 08:57:59 GMT]]></title><description><![CDATA[<p dir="auto">JA, aktien er kun noget værd hvis du går med på emissionen. Pest eller kolera: vælg mellem at nedskrive til nul, eller påtag dig en ny risiko ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8066758</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8066758</guid><dc:creator><![CDATA[exitnu]]></dc:creator><pubDate>Tue, 23 Jan 2024 08:57:59 GMT</pubDate></item></channel></rss>